Dr Seth Lederman is a physician-scientist, entrepreneur, and CEO of Tonix Pharmaceuticals. He talks to Lu Rahman about Tonix Pharmaceuticals’ mission to research and manufacture small molecules and biologics for the treatment of CNS and immunological conditions.  Since its formation in 2011, Tonix Pharmaceuticals has harnessed the power of clinical research and strategic collaborations to develop novel in-house and in-licensed compounds for […]

Shoreline Biosciences secured $140 million in financing to accelerate the growth of its induced pluripotent stem cells (iPSC)-based immunotherapies and support the expansion of its manufacturing capabilities. The financing round comes hot off the heels of two partnerships the company struck this summer valued at $4 billion. Shoreline entered into collaborations with Kite Pharmaceuticals, a Gilead Sciences company, and BeiGene. […]

Shoreline Biosciences’ work developing “off-the-shelf” cell therapies for cancer has led to strategic partnerships with BeiGene and Gilead Sciences. Now those pharmaceutical companies are joining a $140 million investment in the biotech, which will use the cash for the manufacturing and preclinical development of its cell immunotherapies. The financing announced Tuesday comes seven months after Shoreline unveiled […]